ATH434 dose level 1

Drug identity checked against registry records

Also recorded as PBT434

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of ATH434 in Participants with Multiple System AtrophyNCT05109091Alterity TherapeuticsPhase 2Completed2024-11-28Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.